Catherine Lunven

Effects of the Synthetic Thrombin Inhibitor Argatroban on Fibrin- or Clot-Incorporated Thrombin: Comparison with Heparin and Recombinant Hirudin

Christopher N. Berry, Christine Girardot, Catherine Lecoffreo et al. · Thrombosis and Haemostasis · 1994 · 153 citations

Fibrin-bound Human Thrombin, Clot-incorporated Thrombin, Pharmacotherapy +22

SSR182289A, a selective and potent orally active thrombin inhibitor

J.M. Altenburger, Gilbert Lassalle, Mostapha Matrougui et al. · Bioorganic & Medicinal Chemistry · 2004 · 132 citations

Thrombosis, Blood Platelet, Medicine +7

A Randomized Study of the Relative Pharmacokinetics, Pharmacodynamics, and Safety of Alirocumab, a Fully Human Monoclonal Antibody to <scp>PCSK</scp>9, After Single Subcutaneous Administration at Three Different Injection Sites in Healthy Subjects

Catherine Lunven, Tobias Paehler, Franck Poitiers et al. · Cardiovascular Therapeutics · 2014 · 57 citations · Full text

Inhibition by Argatroban, a Specific Thrombin Inhibitor, of Platelet Activation by Fibrin Clot-associated Thrombin

Catherine Lunven, Christiane Gauffeny, Catherine Lecoffre et al. · Thrombosis and Haemostasis · 1996 · 38 citations

Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis

Catherine Berry, Catherine Lunven, Irène Lechaire et al. · British Journal of Pharmacology · 1998 · 27 citations · Full text